These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Characteristics of the T-system of immunity in patients with craniocerebral injuries]. Sokolova TF; Red'kin IuV; Goriachev AN; Sidorov VF Zh Vopr Neirokhir Im N N Burdenko; 1984; (2):27-32. PubMed ID: 6234727 [TBL] [Abstract][Full Text] [Related]
45. [Value of immunologic studies in the assessment of the effects of the dust factor based on the example of artificial mineral fiber substances (silicon carbide)]. Sharshenova AA; Dueva LA; Kupina LM Gig Tr Prof Zabol; 1989; (9):49-51. PubMed ID: 2612954 [No Abstract] [Full Text] [Related]
46. Inhibition or stimulation of immediate, spontaneous rosette formation at various SRBC:lymphocyte ratios. Skopińska E; Nowaczyk M; Zółtowska A; Wojtulewicz-Kurkus J; Wierzchowska E Arch Immunol Ther Exp (Warsz); 1980; 28(4):577-88. PubMed ID: 6970025 [TBL] [Abstract][Full Text] [Related]
47. [Genotoxic effects caused in workers by beryllium compounds]. Gazalieva MA Med Tr Prom Ekol; 2009; (9):32-6. PubMed ID: 19877441 [TBL] [Abstract][Full Text] [Related]
48. [Reaction of spontaneous rosette formation and its inhibition by human antithymus serum in newborn infants]. Berezin VN Pediatriia; 1977 Nov; (11):9-10. PubMed ID: 305028 [No Abstract] [Full Text] [Related]
49. [Behavior of various biochemical indices of liver efficiency and of selected blood serum electrolytes in workers exposed to beryllium]. Cianciara M; Matuszczak D Med Pr; 1977; 28(3):193-200. PubMed ID: 197375 [TBL] [Abstract][Full Text] [Related]
50. Immunity to pulmonary berylliosis in guinea pigs. Reeves AL; Krivanek ND; Busby EK; Swanborg RH Int Arch Arbeitsmed; 1972; 29(3):209-20. PubMed ID: 5036157 [No Abstract] [Full Text] [Related]
51. Beryllium macrophage migration inhibition test. Price CD; Pugh A; Pioli EM; Williams WJ Ann N Y Acad Sci; 1976; 278():204-11. PubMed ID: 786122 [No Abstract] [Full Text] [Related]
52. Beryllium and beryllium compounds. National Toxicology Program Rep Carcinog; 2011; 12():67-70. PubMed ID: 21850112 [No Abstract] [Full Text] [Related]
53. Review of control problems in operations using various beryllium compounds. VILES FJ AMA Arch Ind Health; 1959 Feb; 19(2):239-53. PubMed ID: 13616750 [No Abstract] [Full Text] [Related]
54. [Some points concerning pneumopathy due to beryllium compounds]. POLICARD A; ROCHE L Arch Mal Prof; 1950; 11(2):145-50. PubMed ID: 15419906 [No Abstract] [Full Text] [Related]
55. Pathologic changes induced by beryllium compounds; experimental studies. VORWALD AJ; REEVES AL AMA Arch Ind Health; 1959 Feb; 19(2):190-9. PubMed ID: 13616742 [No Abstract] [Full Text] [Related]
56. Acute inhalation toxicity of beryllium. IV. Beryllium fluoride at exposure concentrations of one and ten milligrams per cubic meter. STOKINGER HE; SPIEGL CJ; ROOT RE; HALL RH; STEADMAN LT; STROUD CA; SCOTT JK; SMITH FA; GARDNER DE AMA Arch Ind Hyg Occup Med; 1953 Dec; 8(6):493-506. PubMed ID: 13103821 [No Abstract] [Full Text] [Related]
57. [Evolution of beryllium pneumoconiosis]. TARA S; DELPLACE Y Arch Mal Prof; 1951; 12(1):37-40. PubMed ID: 14820446 [No Abstract] [Full Text] [Related]
58. A study of humoral and cellular responsiveness in a population occupationally exposed to beryllium. Cianciara MJ; Volkova AP; Aizina NL; Alekseeva OG Int Arch Occup Environ Health; 1980 Jan; 45(1):87-94. PubMed ID: 7364485 [No Abstract] [Full Text] [Related]
59. Skin lesions in persons exposed to beryllium compounds. GRIER RS; NASH P; FREIMAN DG J Ind Hyg Toxicol; 1948 Jul; 30(4):228-37. PubMed ID: 18873564 [No Abstract] [Full Text] [Related]